AVTX
Price
$6.68
Change
+$0.43 (+6.88%)
Updated
Jul 21, 03:48 PM (EDT)
Capitalization
67.67M
MGTX
Price
$8.65
Change
+$0.03 (+0.35%)
Updated
Jul 21, 04:25 PM (EDT)
Capitalization
692.75M
17 days until earnings call
Interact to see
Advertisement

AVTX vs MGTX

Header iconAVTX vs MGTX Comparison
Open Charts AVTX vs MGTXBanner chart's image
Avalo Therapeutics
Price$6.68
Change+$0.43 (+6.88%)
Volume$260
Capitalization67.67M
MeiraGTx Holdings
Price$8.65
Change+$0.03 (+0.35%)
Volume$400
Capitalization692.75M
AVTX vs MGTX Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. MGTX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and MGTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (AVTX: $6.25 vs. MGTX: $8.62)
Brand notoriety: AVTX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 747% vs. MGTX: 79%
Market capitalization -- AVTX: $67.67M vs. MGTX: $692.75M
AVTX [@Biotechnology] is valued at $67.67M. MGTX’s [@Biotechnology] market capitalization is $692.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, AVTX is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 6 TA indicator(s) are bullish while MGTX’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 6 bullish, 4 bearish.
  • MGTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AVTX is a better buy in the short-term than MGTX.

Price Growth

AVTX (@Biotechnology) experienced а +30.75% price change this week, while MGTX (@Biotechnology) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

MGTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($693M) has a higher market cap than AVTX($67.7M). MGTX YTD gains are higher at: 41.544 vs. AVTX (-15.882). AVTX has higher annual earnings (EBITDA): -50.14M vs. MGTX (-141.78M). AVTX has more cash in the bank: 125M vs. MGTX (66.5M). AVTX has less debt than MGTX: AVTX (801K) vs MGTX (80.9M). MGTX has higher revenues than AVTX: MGTX (34.5M) vs AVTX (441K).
AVTXMGTXAVTX / MGTX
Capitalization67.7M693M10%
EBITDA-50.14M-141.78M35%
Gain YTD-15.88241.544-38%
P/E Ratio0.05N/A-
Revenue441K34.5M1%
Total Cash125M66.5M188%
Total Debt801K80.9M1%
FUNDAMENTALS RATINGS
AVTX vs MGTX: Fundamental Ratings
AVTX
MGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
599
PRICE GROWTH RATING
1..100
4437
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGTX's Valuation (77) in the Biotechnology industry is in the same range as AVTX (85) in the Pharmaceuticals Other industry. This means that MGTX’s stock grew similarly to AVTX’s over the last 12 months.

MGTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that MGTX’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's SMR Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for MGTX (99) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than MGTX’s over the last 12 months.

MGTX's Price Growth Rating (37) in the Biotechnology industry is in the same range as AVTX (44) in the Pharmaceuticals Other industry. This means that MGTX’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as MGTX (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXMGTX
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 22 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHYRF0.31N/A
+0.98%
West High Yield Resources Ltd.
BEKAY3.29N/A
N/A
NV Bekaert SA
OLYFF74.94N/A
N/A
Olympia Financial Group, Inc.
NWOEF4.64N/A
N/A
New Oriental Education & Technology Group, Inc.
KSIOF4.28-0.03
-0.68%
kneat.com, Inc.

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+10.42%
FGEN - AVTX
57%
Loosely correlated
-5.20%
LIANY - AVTX
39%
Loosely correlated
+10.00%
MGTX - AVTX
30%
Poorly correlated
N/A
VTGN - AVTX
30%
Poorly correlated
+0.39%
IONS - AVTX
29%
Poorly correlated
-0.97%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with AURA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
N/A
AURA - MGTX
52%
Loosely correlated
-5.76%
IDYA - MGTX
51%
Loosely correlated
-2.26%
KRRO - MGTX
49%
Loosely correlated
-1.16%
RGNX - MGTX
48%
Loosely correlated
-6.10%
SYRE - MGTX
46%
Loosely correlated
-3.55%
More